Cyclomedica Australia PTY Limited   Report issue

For profit Phase 3
Founded: Kingsgrove Australia (1986)

Organization Overview

First Clinical Trial
2012
NCT01458639
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

technegas (2 trials)

xenon xe-133 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Embolism (Phase 3)

Pulmonary Embolism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2